Vigil Neuroscience (VIGL) Stock Highlights

3.96 | -0.75%

2024-10-21 04:47:37

Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brains immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families.

Statistics

Range Today

3.9 4.02

Volume Today 49K

Range 1 Year

2.47 9.24

Volume 1 Year 56.96M

Range 3 Year

2.18 18.27

Volume 3 Year 83.03M

Range 10 Year

2.18 18.27

Volume 10 Year 83.03M

Highlights

Market Capitalization 157M (small)

Floating Shares 20.96M

Current Price 3.96

Price To Earnings -1.87

Price To Book 1.75

Earnings Per Share -2.11

Payout Ratio 0%

Performance

Latest -0.75%

1 Month +13.47%

3 Months +2.06%

6 Months +35.15%

1 Year -40.54%

3 Years -67%

5 Years -67%

10 Years -67%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.